Countering the problem of falsified and substandard drugs / / Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies.
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | Washington, District of Columbia : : National Academies Press,, [2013] 2013 |
| Year of Publication: | 2013 |
| Language: | English |
| Online Access: | |
| Physical Description: | 1 online resource (375 pages) :; illustrations (chiefly color), color maps |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 02359nam a2200445 i 4500 | ||
|---|---|---|---|
| 001 | 5003564286 | ||
| 003 | MiAaPQ | ||
| 005 | 20200520144314.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 140127t20132013dcuab ob 000 0 eng|d | ||
| 020 | |z 0309269393 (pbk.) | ||
| 020 | |z 9780309269391 (pbk.) | ||
| 020 | |a 9780309269407 |q (electronic bk.) | ||
| 035 | |a (MiAaPQ)5003564286 | ||
| 035 | |a (Au-PeEL)EBL3564286 | ||
| 035 | |a (CaPaEBR)ebr10863743 | ||
| 035 | |a (OCoLC)839275199 | ||
| 040 | |a MiAaPQ |b eng |e rda |e pn |c MiAaPQ |d MiAaPQ | ||
| 050 | 4 | |a HD9665.5 |b .I57 2013 | |
| 110 | 2 | |a Institute of Medicine (U.S.). |b Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, |e issuing body. | |
| 245 | 1 | 0 | |a Countering the problem of falsified and substandard drugs / |c Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies. |
| 264 | 1 | |a Washington, District of Columbia : |b National Academies Press, |c [2013] | |
| 264 | 4 | |c 2013 | |
| 300 | |a 1 online resource (375 pages) : |b illustrations (chiefly color), color maps | ||
| 336 | |a text |2 rdacontent | ||
| 337 | |a computer |2 rdamedia | ||
| 338 | |a online resource |2 rdacarrier | ||
| 504 | |a Includes bibliographical references. | ||
| 588 | |a Description based on print version record. | ||
| 590 | |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 | |a Pharmaceutical industry |x Quality control. | |
| 650 | 0 | |a Fraud |x Prevention. | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Buckley, Gillian J., |e editor. | |
| 700 | 1 | |a Gostin, Lawrence O. |q (Lawrence Ogalthorpe), |e editor. | |
| 710 | 2 | |a Institute of Medicine. |b Board on Global Health, |e issuing body. | |
| 776 | 0 | 8 | |i Print version: |a Institute of Medicine (U.S.). |t Countering the problem of falsified and substandard drugs. |d Washington, District of Columbia : National Academies Press, [2013] |h xxiv, 351 pages ; 23 cm |z 9780309269391 |w (DLC)18019897 |
| 797 | 2 | |a ProQuest (Firm) | |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564286 |z Click to View |